Arizona State Retirement System’s Recursion Pharmaceuticals RXRX Stock Holding History

Arizona State Retirement System’s Portfolio RXRX Stock Details RXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$476K	Buy	129,619 +7,913	+7%	+$26.3K	﹤0.01%	1563
2026 Q1	$374K	Buy	121,706 +20,383	+20%	+$78.8K	﹤0.01%	1617
2025 Q4	$414K	Buy	101,323 +6,778	+7%	+$33.6K	﹤0.01%	1584
2025 Q3	$461K	Buy	94,545 +8,153	+9%	+$42.8K	﹤0.01%	1561
2025 Q2	$437K	Buy	86,392 +14,896	+21%	+$73.2K	﹤0.01%	1528
2025 Q1	$378K	Sell	71,496 -239	-0.3%	-$1.74K	﹤0.01%	1554
2024 Q4	$485K	Buy	71,735 +19,063	+36%	+$128K	﹤0.01%	1491
2024 Q3	$347K	Buy	52,672 +4,981	+10%	+$35.7K	﹤0.01%	1689
2024 Q2	$358K	Buy	47,691 +4,760	+11%	+$41.5K	﹤0.01%	1615
2024 Q1	$428K	Buy	42,931 +3,005	+8%	+$33.5K	﹤0.01%	1531
2023 Q4	$394K	Buy	39,926 +3,125	+8%	+$22.3K	﹤0.01%	1588
2023 Q3	$282K	Buy	36,801 +733	+2%	+$7.31K	﹤0.01%	1709
2023 Q2	$269K	Buy	36,068 +20,274	+128%	+$142K	﹤0.01%	1780
2023 Q1	$105K	Buy	15,794 +1,815	+13%	+$14.4K	﹤0.01%	2104
2022 Q4	$108K	Buy	13,979 +622	+5%	+$6.1K	﹤0.01%	2094
2022 Q3	$142K	Buy	13,357 +388	+3%	+$3.93K	﹤0.01%	2014
2022 Q2	$106K	Buy	12,969 +2,188	+20%	+$14.6K	﹤0.01%	2106
2022 Q1	$77K	Buy	10,781 +81	+0.8%	+$861	﹤0.01%	2191
2021 Q4	$183K	Buy	+10,700	New	+$201K	﹤0.01%	2106

Other funds holding RXRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

MCMU

MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Arizona State Retirement System's RXRX Position: Q2 2026 in Review

Arizona State Retirement System increased its Recursion Pharmaceuticals (RXRX) stake by 6.5% in Q2 2026, buying an estimated $26.3K and bringing the position to 129,619 shares worth $476K. The position accounts for ﹤0.01% of the portfolio, ranked #1563.

Arizona State Retirement System first reported a position in RXRX in Q4 2021 and has held it in 19 quarters since. The position peaked at $485K in Q4 2024. 343 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

Arizona State Retirement System held 129,619 shares of Recursion Pharmaceuticals worth $476K as of Q2 2026.
Arizona State Retirement System bought 7,913 Recursion Pharmaceuticals shares in Q2 2026, an estimated $26.3K.
Recursion Pharmaceuticals made up ﹤0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #1563 holding.
Arizona State Retirement System first reported a position in Recursion Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
Arizona State Retirement System's Recursion Pharmaceuticals position peaked at $485K in Q4 2024.
343 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.